6.97
price up icon1.16%   0.08
after-market After Hours: 6.85 -0.12 -1.72%
loading
Lifecore Biomedical Inc stock is traded at $6.97, with a volume of 135.54K. It is up +1.16% in the last 24 hours and up +11.88% over the past month. Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
See More
Previous Close:
$6.89
Open:
$6.93
24h Volume:
135.54K
Relative Volume:
0.62
Market Cap:
$269.91M
Revenue:
$128.45M
Net Income/Loss:
$6.54M
P/E Ratio:
139.40
EPS:
0.05
Net Cash Flow:
$-8.79M
1W Performance:
-4.39%
1M Performance:
+11.88%
6M Performance:
+3.41%
1Y Performance:
+6.09%
1-Day Range:
Value
$6.79
$7.00
1-Week Range:
Value
$6.73
$7.43
52-Week Range:
Value
$3.6793
$7.99

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Name
Lifecore Biomedical Inc
Name
Phone
(952) 368-4300
Name
Address
3515 LYMAN BOULEVARD, CHASKA
Name
Employee
524
Name
Twitter
Name
Next Earnings Date
2025-04-03
Name
Latest SEC Filings
Name
LFCR's Discussions on Twitter

Compare LFCR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
6.97 269.91M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
159.27 70.23B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.74 48.23B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.36 48.22B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.93 18.57B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
301.42 13.29B 2.76B 1.11B 898.10M 22.77

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-05-24 Initiated Craig Hallum Buy
Aug-28-24 Downgrade Barrington Research Outperform → Mkt Perform
Mar-20-23 Downgrade Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Stock (LFCR) Latest News

pulisher
May 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out - ACCESS Newswire

May 08, 2025
pulisher
May 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

May 06, 2025
pulisher
May 02, 2025

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) hedge funds shareholders had a great week as one-year returns increased after a 11% gain last week - Yahoo Finance

May 02, 2025
pulisher
May 02, 2025

A Piece Of The Puzzle Missing From Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Share Price - simplywall.st

May 02, 2025
pulisher
May 01, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

May 01, 2025
pulisher
Apr 27, 2025

Geode Capital Management LLC Raises Stock Holdings in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World

Apr 27, 2025
pulisher
Apr 22, 2025

When the Price of (LFCR) Talks, People Listen - news.stocktradersdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference - The Manila Times

Apr 22, 2025
pulisher
Apr 22, 2025

Quality Management Expert from Lifecore to Chair Strategic Discussion at Major CDMO Conference - Stock Titan

Apr 22, 2025
pulisher
Apr 20, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - markets.businessinsider.com

Apr 20, 2025
pulisher
Apr 16, 2025

Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 16, 2025
pulisher
Apr 16, 2025

Lifecore Appoints Top Legal Executive: Stock Price Targets Set at 5x Current Value - Stock Titan

Apr 16, 2025
pulisher
Apr 15, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - markets.businessinsider.com

Apr 15, 2025
pulisher
Apr 14, 2025

Lifecore Biomedical Taps Thomas Salus as Chief Legal & Administration Officer - Contract Pharma

Apr 14, 2025
pulisher
Apr 14, 2025

Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer - GlobeNewswire

Apr 14, 2025
pulisher
Apr 14, 2025

Lifecore Strengthens Leadership: Former Viatris Legal Chief Joins to Drive Strategic Growth - Stock Titan

Apr 14, 2025
pulisher
Apr 13, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - markets.businessinsider.com

Apr 13, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Makes New $95,000 Investment in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Lifecore Biomedical secures stockholder nod for share issuance - Investing.com Australia

Apr 11, 2025
pulisher
Apr 10, 2025

Lifecore Biomedical secures stockholder nod for share issuance By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Reach Out - markets.businessinsider.com

Apr 10, 2025
pulisher
Apr 07, 2025

LFCR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

Lifecore Biomedical, Inc. Under Investigation: Schall Law Firm Encourages Investors with Losses to Reach Out - ACCESS Newswire

Apr 07, 2025
pulisher
Apr 07, 2025

Hedge funds owners may consider drastic measures as Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) recent US$65m drop adds to long-term losses - simplywall.st

Apr 07, 2025
pulisher
Apr 06, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect - markets.businessinsider.com

Apr 06, 2025
pulisher
Apr 06, 2025

(LFCR) Investment Analysis - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 05, 2025

Lifecore Biomedical’s Earnings Call: Strategic Optimism Amid Challenges - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

Lifecore Biomedical Third Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Apr 05, 2025
pulisher
Apr 05, 2025

Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 05, 2025
pulisher
Apr 04, 2025

Sector Update: Health Care Stocks Fall Late Afternoon - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Top Midday Decliners - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Lifecore Biomedical earnings missed by $0.33, revenue topped estimates - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

Lifecore Biomedical Inc (LFCR) Q3 2025 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire

Apr 04, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical Reports Q3 Fiscal 2025 Results - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical (LFCR) Maintains Outlook Amid Strategic Grow - GuruFocus

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 2027 - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical: Fiscal Q3 Earnings Snapshot - MySA

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical (LFCR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Lifecore Biomedical Inc reports results for the quarter ended February 28Earnings Summary - TradingView

Apr 03, 2025

Lifecore Biomedical Inc Stock (LFCR) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$30.13
price down icon 0.82%
$81.74
price up icon 1.62%
$8.77
price down icon 3.52%
$115.71
price down icon 1.54%
drug_manufacturers_specialty_generic RDY
$13.40
price up icon 1.67%
$301.42
price down icon 2.14%
Cap:     |  Volume (24h):